Dhivya R. Sudhan

UTSW Simmons Comprehensive Cancer Center

2601 North Floyd Road

Richardson, TX 75083

United States

SCHOLARLY PAPERS

2

DOWNLOADS

62

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Hyperactivation of Torc1 Drives Resistance to the Pan-Her Tyrosine Kinase Inhibitor Neratinib in Her2-Mutant Cancers

Number of pages: 43 Posted: 29 Mar 2019 Last Revised: 29 May 2019
Dhivya R. Sudhan, Angel Guerrero-Zotano, Helen Won, Paula González Ericsson, Alberto Servetto, Kyung-min Lee, Luigi Formisano, Yan Guo, Qi Liu, Lisa N. Kinch, Teresa Dugger, James Koch, Richard E. Cutler, Alshad S. Lalani, Richard Bryce, Alan Auerbach, Ariella B. Hanker and Carlos Arteaga
UTSW Simmons Comprehensive Cancer Center, Vanderbilt University - Department of Medicine, Memorial Sloan Kettering Cancer Center - Center for Molecular Oncology, Vanderbilt University - Breast Cancer Program, UTSW Simmons Comprehensive Cancer Center, UTSW Simmons Comprehensive Cancer Center, Vanderbilt University - Department of Medicine, University of New Mexico - Comprehensive Cancer Center, Vanderbilt University - Center for Quantitative Sciences, University of Texas at Dallas - Howard Hughes Medical Institute, Vanderbilt University - Department of Medicine, Vanderbilt University - Department of Medicine, Puma Biotechnology Inc., Puma Biotechnology Inc., Puma Biotechnology Inc., Puma Biotechnology Inc., UTSW Simmons Comprehensive Cancer Center and UTSW Simmons Comprehensive Cancer Center
Downloads 45 (737,222)

Abstract:

Loading...

2.

Co-Occurring Gain-of-Function Mutations in HER2 and HER3 Modulate HER2/HER3 Activation, Breast Cancer Progression, and HER2 Inhibitor Sensitivity

Number of pages: 63 Posted: 12 Oct 2020
Ariella Hanker, S. Harikrishna, Arnaldo Marin, Dan Ye, Chang-Ching Lin, Dhivya R. Sudhan, Hiroaki Akamatsu, Monica Red Brewer, Jonathan Sheehan, James P. Koch, Alberto Servetto, Jie He, Alshad S. Lalani, Jens Meiler and Carlos Arteaga
UTSW Simmons Comprehensive Cancer Center, Vanderbilt University - Department of Chemistry, UTSW Simmons Comprehensive Cancer Center, UTSW Simmons Comprehensive Cancer Center, UTSW Simmons Comprehensive Cancer Center, UTSW Simmons Comprehensive Cancer Center, UTSW Simmons Comprehensive Cancer Center, Vanderbilt University - Department of Medicine, Washington University in St. Louis, Vanderbilt University - Department of Medicine, UTSW Simmons Comprehensive Cancer Center, Foundation Medicine, Inc., Puma Biotechnology Inc., Vanderbilt University - Center for Structural Biology and UTSW Simmons Comprehensive Cancer Center
Downloads 17 (971,245)
Citation 1

Abstract:

Loading...

HER2, HER3, neratinib, PI3K, targeted therapy, Breast cancer, precision oncology